Stellar Biotechnologies (SBOTF) – We’ve Seen The Pump, Now Here Comes The Dump in This BioTech Company
Summary We believe Stellar Biotechnologies' (SBOTF) share price to be a product of a well timed promotional campaign. SBOTF’s share [...]
Summary We believe Stellar Biotechnologies' (SBOTF) share price to be a product of a well timed promotional campaign. SBOTF’s share [...]
Here is an excerpt from our short thesis article on Image Sensing Systems (ISNS) made available to our premium members [...]
Summary Image Sensing Systems’ (ISNS) meteoric rise on the heels of DGLY is totally unwarranted. INSY does not sell ANY [...]
Summary We offer a rebuttal to all four of XXII’s counterarguments to our piece published Wednesday (yesterday) morning. Rather than [...]
Call(s) to Action: WSTI ($0.73) - Yesterday we covered our short position, locking in gains to take advantage of other [...]
Call(s) to Action: MAG ($25.00) - Reported strong Q2 2014 results; Reported non-GAAP EPS of $0.74 more than doubling prior [...]
Call(s) to Action: ESYS ($12.11, up > 13% in early trading) handily beats analyst EPS estimates by 62% with EPS [...]
Call(s) to Action: EXETF ($6.58) - We are adding to our position in EXETF based a SumZero article by Zack [...]